Anno Diegeler, Jochen Börgermann, Utz Kappert, Michael Hilker, Torsten Doenst, Andreas Böning, Marc Albert, Gloria Färber, David Holzhey, Lenard Conradi, Friedrich-Christian Rieß, Philippe Veeckmann, Csaba Minorics, Michael Zacher, Wilko Reents
BACKGROUND: The 30-day and 1-year follow-up analysis of the GOPCABE trial (German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients) revealed no significant difference in the composite end point consisting of death, stroke, myocardial infarction, new renal replacement therapy, or repeat revascularization. The 5-year follow-up data of this trial are reported here. METHODS: From June 2008 to September 2011, a total of 2539 patients aged ≥75 years were randomly assigned to undergo off-pump or on-pump coronary artery bypass grafting (CABG) at 12 centers in Germany...
April 16, 2019: Circulation